Triple

T19772749
Position Surface form Disambiguated ID Type / Status
Subject Array BioPharma E474928 entity
Predicate collaboratedWith P435 FINISHED
Object Celgene NE NERFINISHED

How this triple was built (2 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Celgene | Statement: [Array BioPharma, collaboratedWith, Celgene]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07
Target entity: Celgene
Context triple: [Array BioPharma, collaboratedWith, Celgene]
  • A. Celgene chosen
    Celgene is a biopharmaceutical company known for developing innovative therapies for cancer and inflammatory disorders.
  • B. Janssen Pharmaceuticals
    Janssen Pharmaceuticals is a global pharmaceutical company, part of Johnson & Johnson, known for developing and marketing a wide range of prescription medicines across areas such as immunology, oncology, neuroscience, and cardiovascular disease.
  • C. Janssen Biotech
    Janssen Biotech is a biopharmaceutical company known for developing and manufacturing innovative biologic therapies, including the blockbuster monoclonal antibody Remicade.
  • D. Bristol Myers Squibb
    Bristol Myers Squibb is a global biopharmaceutical company known for developing and manufacturing innovative medicines in areas such as oncology, immunology, and cardiovascular disease.
  • E. Amgen
    Amgen is a leading American biopharmaceutical company known for developing innovative therapies in areas such as oncology, nephrology, and inflammatory diseases.
  • F. None of above.
  • G. Unsure - the case is ambiguous/there is not enough information to decide.

Provenance (2 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69d8e51a43a08190956bc6df13c91a77 completed April 10, 2026, 11:55 a.m.
NER Named-entity recognition batch_69e6535ce4d08190a1dfca2df95a8631 completed April 20, 2026, 4:25 p.m.
Created at: April 10, 2026, 1:48 p.m.